Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez.

Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either transient or persistent (pLBBB). Its long-term impact remains uncertain, though previous studies have linked it to increased risk of ventricular dysfunction and heart failure, with conflicting results as regards mortality.

Bloqueo de rama izquierda

This prospective, multicenter, observational study included 551 patients undergoing TAVR from 2012 to 2021 at a Swiss center, excluding those with prior conduction disorders, preexisting pacemakers, valve-in-valve procedures, or in-hospital mortality. Patients were classified into two groups: those with pLBBB at discharge (n=85; 15%) and those without LBBB or with transient LBBB (n=466; 85%), and followed up to five years. 

Primary endpoint was all-cause mortality and hospitalization for heart failure. Secondary outcomes included need for permanent pacemaker implantation (PPM) and changes in left ventricular ejection fraction (LVEF).

Population mean age was 81, with 58 ± 11% baseline LVEF. 43% of patients were hypertensive, 32% diabetic type 2, and 25% had atrial fibrillation. 78% of cases received a self-expanding valve, and 22% a balloon-expandable valve; predilation was performed in 65% of procedures. The transfemoral approach was used in 92% of patients.

Read also: Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions.

pLBBB was not associated with increased all-cause mortality (HR 1.14; 95% CI: 0.92-1.41; p=0.24) but was linked to higher risk of hospitalization for heart failure (HR 1.34; 95% CI: 1.01-1.76; p=0.04). No significant differences were found in PPM rate (HR 1.45; 95% CI: 0.96-2.18; p=0.07). However, a significant reduction in LVEF was observed among pLBBB patients at follow-up (from 58% ± 11% to 55% ± 12%; p=0.03), while LVEF remained stable among no LBBB patients, or those with transient LBBB (61% ± 10% vs. 60% ± 10%; p=0.45).

Implantation was significantly deeper in pLBBB patietns (4.0 ± 1.8 mm vs. 3.3 ± 1.8 mm; p<0.01), making this the main predictor of pLBBB. Other contributing factors were also analyzed, including a smaller left ventricular outflow tract diameter and aortic annulus and interventricular septum calcification.

Conclusion

In conclusion, pLBBB occurred in 15% of patients without a history of conduction disorders or pacemakers and was associated with higher risk of hospitalization for heart failure and progressive LVEF deterioration. However, no significant impact was identified on overall mortality or the need for pacemaker implantation.

Original Title: Long-Term Outcomes After Transcatheter Aortic Valve Replacement Complicated by New-Onset Persistent Left Bundle Branch Block.

Reference: Carmen Hodel et al. Catheterization and Cardiovascular Interventions, 2025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...